Search for: "SANOFI-AVENTIS V SANDOZ"
Results 1 - 20
of 54
Sorted by Relevance
|
Sort by Date
26 Dec 2010, 9:59 pm
By Donald Zuhn -- Last week, in Sanofi-Aventis v. [read post]
10 Sep 2009, 9:59 pm
The case, Sanofi-Aventis U.S. [read post]
17 Jun 2007, 7:53 pm
Sanofi-Aventis U.S. [read post]
2 Apr 2011, 11:58 pm
Sanofi-Aventis U.S. [read post]
2 Jul 2007, 2:51 pm
Dermik Labs Eloxatin: Sanofi-Aventis v. [read post]
6 May 2007, 9:06 pm
Ambien CR: Sanofi-Aventis v. [read post]
2 Apr 2007, 9:52 pm
Exela Pharmsci Ambien CR: Sanofi-Aventis v. [read post]
6 Aug 2007, 8:38 pm
Mylan Eloxatin: Sanofi-Aventis v. [read post]
14 Nov 2007, 8:59 pm
Mylan Taxotere: Sanofi-Aventis v. [read post]
16 Sep 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: CAFC reverses District Court finding that generic Eloxatins do not infringe Sanofi’s patent; More claim construction confusion: Sanofi-Aventis v Sandoz (Patent Docs) (Patents4Life) (GenericsWeb) Mircera (Erythropoietin) – US: CAFC affirms… [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]
26 Aug 2010, 10:01 am
Karst – When we attended the August 17th hearing in Sanofi-aventis U.S. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General… [read post]
1 Dec 2009, 9:45 am
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
7 Feb 2012, 2:25 pm
’s (“Sandoz’s”) ANDA No. 077857 for a generic version of Sanofi-aventis U.S. [read post]
29 Jun 2018, 7:50 am
In 2006, with the encouragement of Sanofi-Aventis, USP began to consider a standard for testing enoxaparin. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
